Literature DB >> 28033441

The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries.

Oluf Dimitri Røe1,2.   

Abstract

Mesh:

Year:  2017        PMID: 28033441     DOI: 10.1001/jamaoncol.2016.6335

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks.

Authors:  Toon van der Gronde; Carin A Uyl-de Groot; Toine Pieters
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

2.  End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study.

Authors:  Zhong Li; Zijing Pan; Liang Zhang; Ruibo He; Shan Jiang; Chengzhong Xu; Fangfang Lu; Pei Zhang; Boyang Li
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

3.  Socioeconomic inequality in health care use among cancer patients in China: Evidence from the China health and retirement longitudinal study.

Authors:  Huiru Zhang; Yu Fu; Mingsheng Chen; Lei Si
Journal:  Front Public Health       Date:  2022-08-02

4.  Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells.

Authors:  Raihana Rosman; Bullo Saifullah; Sandra Maniam; Dena Dorniani; Mohd Zobir Hussein; Sharida Fakurazi
Journal:  Nanomaterials (Basel)       Date:  2018-02-02       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.